Biogen Inc.

NAS: BIIB

GO
/marketstate/country/us

Market open

/zigman2/quotes/201531540/composite

$

294.57

Change

+4.63 +1.60%

Volume

Volume 578,254

Aug 12, 2020, 2:30 p.m.

Real time quotes

/zigman2/quotes/201531540/composite

Previous close

$ 289.94

$ 294.57

Change

+4.63 +1.60%

Day low

Day high

$290.69

$296.27

Open
Open: 290.69

52 week low

52 week high

$215.78

$374.99

Open

Market cap

$45.90B

Average volume

1.62M

P/E ratio

8.63

Rev. per Employee

$1.55M

EPS

34.14

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/biib

MarketWatch News on BIIB

  1. Health-Care Reform Under Biden/Harris Would Be “Measured,” RBC Says

    1:01 p.m. Today

    - Connor Smith

  2. FDA approves Roche's new spinal muscular atrophy drug

    10:40 a.m. Aug. 8, 2020

    - Jaimy Lee

  3. Here’s What Kodak Pharmaceutical Might Be Worth

    7:59 a.m. Aug. 5, 2020

    - Al Root

  4. Biogen Gains, Hasbro Drops as the Dow Inches Higher

    1:48 p.m. July 27, 2020

    - Teresa Rivas

  5. Biogen double upgraded to overweight at Morgan Stanley

    11:16 a.m. July 27, 2020

    - Tomi Kilgore

  6. Buy Biogen Stock, Says Morgan Stanley, Because the Time Is Right

    10:20 a.m. July 27, 2020

    - Josh Nathan-Kazis

  7. Stocks Edge Ahead on Vaccine, Earnings Hopes

    1:01 p.m. July 22, 2020

    - Teresa Rivas

  8. Biogen Beats Earnings Expectations but Leaves a Mystery on CFO

    9:02 a.m. July 22, 2020

    - Josh Nathan-Kazis

  9. Biogen's stock rises after big earnings beat, raised outlook

    7:30 a.m. July 22, 2020

    - Tomi Kilgore

  10. Biogen shares up 1.6% premarket

    7:24 a.m. July 22, 2020

    - Ciara Linnane

  11. Biogen now sees full-year revenue about $13.8 bln to $14.2 bln vs. prior $14.0 bln to $14.3 bln

    7:24 a.m. July 22, 2020

    - Ciara Linnane

  12. Biogen now sees full-year adj. EPS of $34.00 to $36.00 vs. prior $31.50 to $33.50

    7:23 a.m. July 22, 2020

    - Ciara Linnane

  13. Biogen now sees full-year EPS $32.00 to $34.00 vs. prior $29.50 to $31.50

    7:23 a.m. July 22, 2020

    - Ciara Linnane

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/biib

Other News on BIIB

  1. Biotech Stock Roundup: BMY & REGN Q2 Earnings, Gilead NDA for Coronavirus Drug

    12:23 p.m. Today

    - Zacks.com

  2. Short Sellers Shy Away From Big Biotech

    7:26 a.m. Today

    - 247WallSt.com

  3. Biogen: An Undervalued Opportunity In An Overpriced Market

    12:59 a.m. Aug. 11, 2020

    - Seeking Alpha

  4. How Will Biotech ETFs React to Q2 Earnings Release?

    4:42 p.m. Aug. 10, 2020

    - Zacks.com

  5. The 8 Best Stocks in Warren Buffett’s Pocket Right Now

    11:38 a.m. Aug. 10, 2020

    - InvestorPlace.com

  6. Large Caps Close Mostly Higher Friday

    3:16 p.m. Aug. 9, 2020

    - GuruFocus.com

  7. BIIB, GRPN among premarket gainers

    8:20 a.m. Aug. 7, 2020

    - Seeking Alpha

  8. Biogen up 12% on FDA acceptance of aducanumab application

    7:40 a.m. Aug. 7, 2020

    - Seeking Alpha

  9. Loading more headlines...
/news/pressrelease/company/us/biib

Press Releases on BIIB

  1. Nasdaq 100 Movers: ILMN, BIIB

    10:25 a.m. Aug. 7, 2020

    - MarketNewsVideo.com

  2. S&P 500 Movers: ILMN, BIIB

    10:24 a.m. Aug. 7, 2020

    - MarketNewsVideo.com

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.